Soleno Therapeutics (SLNO) had the highest return between 2023 and 2024 by a mid-cap US stock, returning 2,050.7%.

ASSET	YEARS	% RETURN
Soleno Therapeutics (SLNO)	2023-2024	2,050.72%
Innodata (INOD)	2023-2024	1,183.12%
SoundHound AI (SOUN)	2023-2024	1,033.71%
Sezzle (SEZL)	2023-2024	1,029.36%
Quantum Computing (QUBT)	2023-2024	954.14%
Dave (DAVE)	2023-2024	836.64%
GeneDx (WGS)	2023-2024	762.63%
Terawulf (WULF)	2023-2024	744.78%
Cipher Mining (CIFR)	2023-2024	702.77%
Grupo Financiero Galicia SA ADR (GGAL)	2023-2024	650.31%
Banco Macro SA B ADR (BMA)	2023-2024	611.41%
Trump Media & Technology (DJTWW)	2023-2024	564.7%
American Superconductor (AMSC)	2023-2024	560.32%
Powell Industries (POWL)	2023-2024	544.7%
Abercrombie & Fitch (ANF)	2023-2024	543.16%
BigBearai (BBAI)	2023-2024	521.51%
BBVA Banco Frances SA ADR (BBAR)	2023-2024	510.89%
SkyWest (SKYW)	2023-2024	496.37%
Modine Manufacturing (MOD)	2023-2024	475.91%
IES (IESC)	2023-2024	469.29%
Oscar Health (OSCR)	2023-2024	437.6%
Centessa Pharmaceuticals PLC ADR (CNTA)	2023-2024	420.19%
Cellebrite DI (CLBT)	2023-2024	401.82%
Archer Aviation (ACHR)	2023-2024	394.92%
Hut 8 Corp Common Stock (HUT)	2023-2024	380.31%

Mid-cap stocks are treated as having a market cap between $2B and $10B.